None listed
Conditions
Interventions
Intervention1: Test Product:
1. SA-CS-GD-1 (Cream with
active)
2. SA-CS-B-1 (Base Cream): Dose: Gently massage approx. 1 drop of over one block as assigned (forearm) Route of Administration: Topical
Sponsors
Galaxy Surfactants Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Gender: Male or Female 18 to 40 2. Subjects willing to give written informed consent 3. Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 4. Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 5. Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial)
Exclusion criteria
Exclusion criteria: 1. Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study. 2. Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last years, or any other confounding skin condition. 3. Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product. 4. Have participated in any interventional clinical trial in the previous 90 days. 5. Have a known sensitivity to any of the constituents of the test product 6. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in hydrationTimepoint: T0min, T30min, T+2hrs, T+8hrs, T+24hrs, T+ 48hours, T+72hrs | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in TEWLTimepoint: t0min, t30min, t24hrs, t48hrs, t72hrs | — |
Countries
India
Contacts
Public ContactPuneet Mittal
CCFT Laboratories
Outcome results
None listed